ABSTRACT
In the healthcare industry, many artificial intelligence (AI) models have attempted to overcome bias from class imbalances while also maintaining high results. Firstly, when utilizing a large number of unbalanced samples, current AI models and related research have failed to balance specificity and sensitivity – a problem that can undermine the reliability of medical research. Secondly, no reliable method for obtaining detailed interpretability has been put forth when addressing large numbers of input features. The present research addresses these two critical research gaps with a proposed lightweight Artificial Neural Network (ANN) model. Using 43 input features from the 2021 Behavioral Risk Factor Surveillance System (BRFSS) dataset, the proposed model outperforms prior models in producing balanced outcomes from markedly unbalanced large survey data. The efficacy of this proposed ANN model is attributed to its simplified design, which reduces processing demands, and its resilience in identifying the probability of myocardial infarction (MI). This is demonstrated by its 80% specificity and 77% sensitivity, and is substantiated by a Receiver Operating Characteristic Area Under the Curve (AUC) of 0.87. The outcomes across the scopes of each specified data domain were also separately represented, thus demonstrating the proposed model’s robust sensitivity. The interpretability of the model, as measured by Shapley values, reveals substantial correlations between myocardial infarction (MI) and its risk factors, including long-term medical conditions, socio-demographic factors, personal health habits, economic and social status, healthcare availability and affordability, as well as impairment statuses, providing valuable insights for improved cardiovascular risk assessment and personalized healthcare strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Behavioral Risk Factor Surveillance System https://www.cdc.gov/brfss/index.html
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
